Individualised short-term therapy for adolescents impaired by attention-deficit/hyperactivity disorder despite previous routine care treatment (ESCAadol)—Study protocol of a randomised controlled trial within the consortium ESCAlife

Peer Review reports

Original Submission
31 Jan 2018	Submitted	Original manuscript
7 Mar 2018	Reviewed	Reviewer Report - Wai Tong Chien
9 Apr 2018	Author responded	Author comments - Julia Geissler
Resubmission - Version 2
9 Apr 2018	Submitted	Manuscript version 2
Publishing
10 Apr 2018	Editorially accepted
27 Apr 2018	Article published	10.1186/s13063-018-2635-2

Back to article page